Article
An agent with good coverage against staphylococci and streptococci will eradicate the vast majority of typical cellulitis cases.
DELTA 3 Showcases Long-Term Safety and Efficacy of Delgocitinib for Chronic Hand Eczema
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
ESK-001: A Conversation with Jörn Drappa, MD, PhD, of Alumis on Breakthrough Data and the Future of Psoriasis Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Journey Medical Launches Emrosi, a Dual-Release Minocycline for Rosacea
Do CBD Products Belong in Therapeutic Dermatology?